| 000 | 01616 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516135035.0 | ||
| 264 | 0 | _c20130701 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1423-0232 | ||
| 024 | 7 |
_a10.1159/000345558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMontella, Liliana | |
| 245 | 0 | 0 |
_aSorafenib in elderly patients with advanced hepatocellular carcinoma: a case series. _h[electronic resource] |
| 260 |
_bOncology _c2013 |
||
| 300 |
_a265-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAddeo, Raffaele | |
| 700 | 1 | _aCennamo, Gregorio | |
| 700 | 1 | _aVincenzi, Bruno | |
| 700 | 1 | _aPalmieri, Rita | |
| 700 | 1 | _aSperlongano, Pasquale | |
| 700 | 1 | _aSperlongano, Rossella | |
| 700 | 1 | _aIodice, Patrizia | |
| 700 | 1 | _aRusso, Paola | |
| 700 | 1 | _aDel Prete, Salvatore | |
| 773 | 0 |
_tOncology _gvol. 84 _gno. 5 _gp. 265-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000345558 _zAvailable from publisher's website |
| 999 |
_c22522813 _d22522813 |
||